StockCIK 1001316

TG THERAPEUTICS, INC. (TGTX): Insider Trades and Fund Holdings

In the past 12 months, TG THERAPEUTICS, INC. insiders reported 0 open-market purchases worth $0 and 1 sale worth $275K; 0 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$275KSold by insiders, 12 months

2Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 14, 2026.

Recent TGTX insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 14	Sep 10	Laurence N. CharneyDirector	Director	▼ SELL	5,000	54.96	$275K	−2.9%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Laurence N. Charney	Director	0	$0	1	$275K	Sep 14, 2026

Tracked funds that report TGTX

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	679,300	$37.3M	0.05%	▲ +99.3%
Bridgewater Associates	Q2 2026	429,904	$23.6M	0.10%	▲ +38.0%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →